0001104659-22-005976.txt : 20220120
0001104659-22-005976.hdr.sgml : 20220120
20220120165035
ACCESSION NUMBER: 0001104659-22-005976
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220118
FILED AS OF DATE: 20220120
DATE AS OF CHANGE: 20220120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Utter Christine Marie
CENTRAL INDEX KEY: 0001707685
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 22542911
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
tm224053-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-18
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001707685
Utter Christine Marie
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
0
1
0
0
SVP, Finance & CAO
Common Stock
2022-01-18
4
S
0
1428
43.5
D
26425
D
Common Stock
2022-01-18
4
M
0
10000
18.01
A
36425
D
Common Stock
2022-01-18
4
S
0
10000
44
D
26425
D
Stock Option (Right to Buy)
18.01
2022-01-18
4
M
0
10000
18.01
D
2028-01-02
Common Stock
10000
0
D
Stock Option (Right to Buy)
40.45
2024-09-23
Common Stock
4688
4688
D
Stock Option (Right to Buy)
51
2025-01-02
Common Stock
17800
17800
D
Stock Option (Right to Buy)
33.02
2029-01-21
Common Stock
21250
21250
D
Stock Option (Right to Buy)
33.02
2029-01-21
Common Stock
10100
10100
D
Stock Option (Right to Buy)
51.16
2030-01-28
Common Stock
23800
23800
D
Stock Option (Right to Buy)
66.49
2031-01-05
Common Stock
50750
50750
D
Stock Option (Right to Buy)
38.1
2032-01-06
Common Stock
43500
43500
D
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2021.
Currently exercisable.
This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.
This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021.
Represents an option award of 33,250 options and an option award of 17,500 options. These option awards were each granted on January 6, 2021, and each vests over four years, with 25% ofthe shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-monthperiod thereafter, beginning on April 6, 2022.
This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.
/s/ Avraham S. Adler, attorney-in-fact
2022-01-20